Phaarmasia Ltd is Rated Hold by MarketsMOJO

12 hours ago
share
Share Via
Phaarmasia Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 09 Feb 2026. While the rating was revised earlier this year, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 29 May 2026, providing investors with an up-to-date view of the company’s position in the Pharmaceuticals & Biotechnology sector.
Phaarmasia Ltd is Rated Hold by MarketsMOJO

Understanding the Current Rating

The 'Hold' rating assigned to Phaarmasia Ltd indicates a balanced outlook for investors, suggesting that the stock is expected to perform in line with the market or sector averages in the near term. This rating reflects a combination of factors including the company’s quality, valuation, financial trend, and technical indicators. It advises investors to maintain their current holdings rather than aggressively buying or selling the stock.

Quality Assessment

As of 29 May 2026, Phaarmasia Ltd’s quality grade is assessed as below average. This is primarily due to the company’s weak long-term fundamental strength, highlighted by an average Return on Equity (ROE) of just 1.45%. Such a low ROE suggests limited efficiency in generating profits from shareholders’ equity over time. Additionally, the company’s ability to service its debt is concerning, with an average EBIT to Interest ratio of -0.99, indicating operational earnings are insufficient to cover interest expenses. These factors temper the overall quality outlook despite recent improvements in profitability.

Valuation Perspective

Contrasting its quality metrics, Phaarmasia Ltd’s valuation is very attractive as of today. The stock trades at a Price to Book Value of 4.9, which is considered a discount relative to its peers’ historical valuations. This valuation attractiveness is supported by a robust Return on Equity of 20.7% in the latest period, signalling improved capital efficiency. Furthermore, the company’s Price/Earnings to Growth (PEG) ratio stands at a low 0.1, indicating that the stock’s price growth is favourable compared to its earnings growth rate. Such valuation metrics suggest that the stock may offer value opportunities for investors willing to look beyond short-term volatility.

Financial Trend and Profitability

The financial trend for Phaarmasia Ltd is very positive as of 29 May 2026. The company has demonstrated remarkable growth in net profit, with an increase of 835.06% reported in December 2025. This surge is further supported by positive results declared for two consecutive quarters, signalling a sustained turnaround. The latest six-month figures show a Profit After Tax (PAT) of ₹2.48 crores, growing at an impressive 285.22%, alongside net sales rising to ₹32.60 crores. Return on Capital Employed (ROCE) for the half-year period reached 7.91%, the highest recorded recently, indicating more efficient use of capital. These strong financial trends underpin the 'Hold' rating by reflecting improving operational performance and profitability.

Technical Indicators

From a technical standpoint, Phaarmasia Ltd is mildly bullish. The stock’s price movements over various time frames show mixed results: a flat 0.00% change over the last day, a decline of 4.19% over the past week, and a sharper drop of 17.16% in the last month. However, the six-month return is positive at 23.68%, and the one-year return is exceptionally strong at 179.80%. Year-to-date, the stock has declined by 31.30%, reflecting some recent volatility. These technical signals suggest cautious optimism, with the stock showing resilience over longer periods despite short-term fluctuations.

Investor Implications

For investors, the 'Hold' rating on Phaarmasia Ltd implies that the stock currently offers a balanced risk-reward profile. The company’s very attractive valuation and strong recent financial performance provide reasons for confidence, while the below-average quality metrics and mixed technical signals counsel prudence. Investors should monitor ongoing quarterly results and sector developments closely, as further improvements in fundamentals or technical momentum could influence future rating adjustments.

Company Profile and Market Context

Phaarmasia Ltd operates within the Pharmaceuticals & Biotechnology sector as a microcap entity. The company’s majority shareholders are promoters, which often indicates stable ownership and potential alignment with shareholder interests. Despite its small market capitalisation, the company’s recent financial turnaround and valuation appeal have attracted attention from investors seeking opportunities in the sector.

Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!

  • - Recently turned profitable
  • - Strong business fundamentals
  • - Pre-breakout opportunity

Catch the Breakout Early →

Summary of Key Metrics as of 29 May 2026

The latest data shows that Phaarmasia Ltd’s stock returns have been volatile but overall positive over the past year, with a 179.80% gain. The company’s net profit growth of 835.06% and PAT growth of 285.22% over the last six months highlight a strong financial turnaround. Despite a below-average quality grade, the valuation remains very attractive, supported by a PEG ratio of 0.1 and a Price to Book Value of 4.9. Technical indicators suggest a mildly bullish trend, though recent short-term declines warrant attention.

Conclusion

In conclusion, Phaarmasia Ltd’s 'Hold' rating by MarketsMOJO reflects a nuanced view of the company’s current position. Investors are advised to consider the company’s improving financial trends and attractive valuation alongside its quality challenges and technical volatility. Maintaining a balanced approach with close monitoring of future developments will be key for those holding or considering this stock within their portfolios.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News